
Orphan drug developer Minoryx raises €51m
The Series C round was co-led by Columbus Venture Partners and Caixa Capital Risc, and supported by CDTI Innvierte, Fund+, Ysios Capital and other...

TWB partners with Processium and Syngulon
With the new partnerships, TWB optimizes the support of projects led by hosted startups and industry partners. Processium is specialised in...

Andera Partners co-leads $118m Series B of Mineralys thx (USA)
Mineralys plans to use the proceeds to continue to advance MLS-101, a highly selective aldosterone synthase inhibitor. MLS-101 is currently being...

Mimetas BV participating in €325m cancer funding
As part of a financing of the Dutch Naional Growth Fund the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) initiative has been granted...

G7 heads call for decarbonisation of industry
The G7 ministers underlined the importance of efforts to improve energy efficiency, the need for increased investment in renewable energy, tracking...

Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
sAurobac Therapeutics SAS goal is to create next-generation antimicrobials and diagnostics to fight Antimicrobial Resistance (AMR). Decades ago,...

GeNeuro finds biologic against post-COVID syndrome
The results of a collaboration of GeNeuro with the FondaMental Foundation were presented at the Schizophrenia International Research Society (SIRS)...